Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 1
1913 1
1946 6
1947 7
1948 8
1949 9
1950 5
1951 11
1952 11
1953 8
1954 12
1955 14
1956 19
1957 22
1958 28
1959 12
1960 18
1961 17
1962 18
1963 24
1964 38
1965 22
1966 14
1967 23
1968 27
1969 32
1970 25
1971 29
1972 24
1973 28
1974 31
1975 30
1976 31
1977 28
1978 22
1979 25
1980 24
1981 27
1982 30
1983 25
1984 45
1985 56
1986 43
1987 61
1988 62
1989 45
1990 56
1991 54
1992 71
1993 44
1994 57
1995 61
1996 54
1997 46
1998 50
1999 54
2000 43
2001 66
2002 59
2003 50
2004 51
2005 62
2006 74
2007 85
2008 87
2009 81
2010 83
2011 104
2012 112
2013 114
2014 94
2015 117
2016 119
2017 102
2018 103
2019 96
2020 122
2021 143
2022 143
2023 132
2024 138
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,782 results

Results by year

Filters applied: . Clear all
Page 1
Pathogenesis of liver fibrosis.
Hernandez-Gea V, Friedman SL. Hernandez-Gea V, et al. Among authors: friedman sl. Annu Rev Pathol. 2011;6:425-56. doi: 10.1146/annurev-pathol-011110-130246. Annu Rev Pathol. 2011. PMID: 21073339 Review.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Španić T, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ; OlympiA Clinical Trial Steering Committee and Investigators. Geyer CE Jr, et al. Among authors: friedman s. Ann Oncol. 2022 Dec;33(12):1250-1268. doi: 10.1016/j.annonc.2022.09.159. Epub 2022 Oct 10. Ann Oncol. 2022. PMID: 36228963 Free PMC article. Clinical Trial.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. Among authors: friedman sm. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation.
Khurshid S, Friedman S, Reeder C, Di Achille P, Diamant N, Singh P, Harrington LX, Wang X, Al-Alusi MA, Sarma G, Foulkes AS, Ellinor PT, Anderson CD, Ho JE, Philippakis AA, Batra P, Lubitz SA. Khurshid S, et al. Among authors: friedman s. Circulation. 2022 Jan 11;145(2):122-133. doi: 10.1161/CIRCULATIONAHA.121.057480. Epub 2021 Nov 8. Circulation. 2022. PMID: 34743566 Free PMC article.
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.
Martin-Serrano MA, Kepecs B, Torres-Martin M, Bramel ER, Haber PK, Merritt E, Rialdi A, Param NJ, Maeda M, Lindblad KE, Carter JK, Barcena-Varela M, Mazzaferro V, Schwartz M, Affo S, Schwabe RF, Villanueva A, Guccione E, Friedman SL, Lujambio A, Tocheva A, Llovet JM, Thung SN, Tsankov AM, Sia D. Martin-Serrano MA, et al. Among authors: friedman sl. Gut. 2023 Apr;72(4):736-748. doi: 10.1136/gutjnl-2021-326514. Epub 2022 May 18. Gut. 2023. PMID: 35584893 Free PMC article.
Focus.
Friedman SL. Friedman SL. J Hepatol. 2011 Jul;55(1):1-2. doi: 10.1016/j.jhep.2011.03.001. Epub 2011 Mar 22. J Hepatol. 2011. PMID: 21396971 Free article. No abstract available.
3,782 results